Epigenetics calls for papers / meetings & conferences

Call for Abstracts: Markers in Cancer 2012

October 11-13, 2012 Holywood, Florida

Deadline for submission: June 19, 2012, by 11:59 PM (EDT)

Abstracts must be submitted online using the official Markers in Cancer 2012 Abstract Submitter. E-mails and word processing files submitted outside this program will not be accepted. Each First Author will receive an e-mail to verify the abstract has been received.

Markers in Cancer 2012 (formerly known as the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer) will stimulate discussion on the use of biomarkers as a tool for optimizing detection and treatment in oncology.

Designed for clinicians, pathologists, clinical and translational researchers, statisticians, radiologists, and others who specialize in molecular diagnostics, the meeting will present the latest advances in cancer markers to assess drug efficacy, improve prognostic and predictive evaluations and imaging, and enhance clinical trial development.

This year's Meeting will focus on practice-oriented translational research. Join us in Florida to review and explore the latest innovations in cancer markers.

Authors must select one topic category that best fits the subject of their abstract. The Markers in Cancer Scientific Committee reserves the right to recategorize an abstract.

Clinical Evaluation of Biomarkers, including:
- Biomarker Readiness for Clinical Application
- Assay Validation
- Clinical Qualification
Imaging Biomarkers
Immune System and Immunotherapeutic Markers
Mechanism-based Markers of Resistance and Toxicity
Blood-based Markers, including:
- Circulating Tumor Cells/Cancer Stem Cells
- Plasma DNA
- Proteomics
Cell Signaling Pathways
Genetics, Genomics, Epigenetics, and Gene Expression, including:
- Bioinformatics in Biomarker Research
- Early Translation of Multi-Dimensional Markers
Regulatory Science, Policy, and Knowledge Transfer, including:
- Implementation Science
- Ethics
- IDE and Companion In Vitro Diagnostics
- Regulatory and Policy Considerations, Especially Cross-National
Other

Call for Papers: Epigenomics Session at the Pacific Symposium on Biocomputing 2013

January 3-7, 2013 The Big Island of Hawaii

Scientists have known for a long time that the sequence of nucleotides that comprise the genome is not sufficient to explain the heritability of traits from one generation to the next, nor is that sequence sufficient to drive the myriad functions of a living cell. Recently, however, catalyzed by the rapid acquisition of a wide variety of genome-scale data sets from projects such as ENCODE, modENCODE, and the Epigenomics Roadmap, scientists have begun to recognize just how much information is encoded beyond the primary DNA sequence. Accordingly, many of the central questions facing biology today concern the interpretation and integration of epigenomic data with our existing knowledge of the molecular pathways within the cell, including DNA, RNA, proteins, and metabolites.

This session will focus on computational methods for the analysis and interpretation of various types of epigenomic data. We define the phenomena that fall under this heading fairly broadly, including histone modifications, DNA methylation, nucleosome positioning, chromatin structure and accessibility, and DNA-DNA interaction. The session will include papers that describe methods for building computational models of physical phenomena as well as methods for interpreting the functional significance of epigenomic data. Such papers may describe either the development and validation of novel analytical methods or the application of existing methods to novel data sets. Papers may describe methods for interpreting a single type of epigenomic data or methods for integrating heterogeneous data types. Overall, the session will emphasize techniques that are applicable on a genome-wide scale; however, recognizing the value in detailed analysis of small sets of well-studied loci, we welcome such submissions if the analysis yields broader insights, either methodological or biological.

Key dates

Paper submission deadline: July 31, 2012
Notification of acceptance/rejection: September 10, 2012
Camera-ready final paper deadline: October 1, 2012

Submission guidelines

The scientific core of the conference consists of rigorously peer-reviewed full-length papers reporting on original work. Accepted papers will be published in an archival proceedings volume (fully indexed in PubMed), and a number of the papers will be selected for presentation during the conference.

Please see the PSB paper format template and instructions at http://psb.stanford.edu/psb-online/psb-submit.

Organizing committee

Alexander J. Hartemink, Alexander F. Hehmeyer Associate Professor of Computer Science, Statistical Science, and Biology at Duke University
Manolis Kellis, Associate Professor, Department of Computer Science and Engineering, Massachusetts Institute of Technology
William Stafford Noble, Professor, Department of Genome Sciences and Department of Computer Science and Engineering, University of Washington
Zhiping Weng, Professor, Program in Bioinformatics and Integrative Biology and Department of Molecular Pharmacology, University of Massachusetts Medical School

Please direct questions to William Noble (william-noble@uw.edu).

Call for Abstracts: Mathematical and Computational Medicine Conference 2012

Saturday December 1 2012 - Wednesday December 5 2012 Xcaret, Mexico

The purpose of the Zing Conference on Mathematical and Computational Medicine is to bring together eminent scholars with expertise in various fields of mathematical and computational medicine, as well as experimentalists and medical doctors interested in application of computational methods in clinical studies. The mathematical and computational medicine is now one of the most important and rapidly growing fields of modern medicine, and will become even more important in nearest future, when the cost of individual human gene sequencing becomes affordable for mass-scale clinical use (The $1000 Human Genome). New sequencing techniques, such as RNA-Seq produce enormous amount of information on the transcriptome in healthy and diseased cells, that need a development of new mathematical and computational methods to extract the most important medical information. The scope of the proposed Zing Conference will cover many different fields mathematical and computational medicine and biomedical informatics, such as genetics, genomics, epigenetics, and epigenomics of various diseases including mental and learning disorders, autism, and somatic diseases, with a special emphasis on cancer, protein misfolding disorders related to amyloid formation in neurogenerative diseases (such as Alzheimer's and Parkinson's disease), gene regulation, biomarker development, computer aided drug development, computational pharmacodynamics, computational immunology, systems biology and its extension to systems medicine, machine learning methods in application to biomedical data, applicability of computational methods in personalized medicine, and regenerative medicine. A special session will be devoted to errors in measurements of biomedical data and statistical evidence-based medicine.

Talk abstract deadline: Saturday June 30 2012
Poster abstract deadline: Monday October 1 2012

For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

For queries about scientific content, presentations, posters, etc. please email info~at~zingconferences.com (replace '~at~' with '@').